Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis
Clinical Pharmacology & Therapeutics · 2025-01 · 117 (1) · 28-33
DOI: 10.1002/cpt.3416 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 20.08.2024. Verfasst von Christina M Lockwood und 18 weiteren Autor:innen. Beteiligte Einrichtung: Association for Molecular Pathology, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Practice Guidelines as Topic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BLOODPAC is a public‐private consortium that develops best practices, coordinates clinical and translational research, and manages the BLOODPAC Data Commons to broadly support the liquid biopsy community and accelerate regulatory review to aid patient accessibility. BLOODPAC previously recommended 11 preanalytical minimal technical data elements (MTDEs) for BLOODPAC‐sponsored studies and data submitted to BLOODPAC Data Commons. The current landscape analysis evaluates the overlap of the BLOODPAC MTDEs with current best practices, guidelines, and standards documents related to clinical and research liquid biopsy applications. Our findings indicate an existing high degree of concordance among these documents. Where differences exist, the BLOODPAC preanalytical MTDEs can be considered a minimal practicable set for organizations to utilize. These MTDEs were developed following extensive examination of best practices and iterative conversations with the U.S. FDA. BLOODPAC recommends the use of these MTDEs in submissions to data commons and to support liquid biopsy clinical trials and research globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Association for Molecular Pathology, Rockville, Maryland, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- American Society of Clinical Oncology, Alexandria, Virginia, USA.
- Department of Pathology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- American Cancer Society, Atlanta, Georgia, USA.
- School of Life Sciences, Arizona State University, Phoenix, Arizona, USA.
ORCID-Profile: Christina M Lockwood, Jason D Merker, Elizabeth Bain, Caroline Compton, Robert L Grossman, Frederick Jones, Jerry S H Lee, Jean-Francois Martini, Lauren Saunders, Howard Scher, Stella Somiari, Mark Stewart, Jacob Vinson
Förderung
- NCI NIH HHS
Zitieren
APA
Lockwood, C. M., Merker, J. D., Bain, E., Compton, C., Grossman, R. L., Johann, D., Jones, F., Jones, G., Kreifels, M., LeBlang, S., Lee, J. S. H., Lyle, J., Martini, J. F., Saunders, L., Scher, H., Somiari, S., Stewart, M., Vinson, J., & Leiman, L. C. (2025). Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis. Clinical Pharmacology & Therapeutics, 117(1), 28-33. https://doi.org/10.1002/cpt.3416
Vancouver
Lockwood CM, Merker JD, Bain E, Compton C, Grossman RL, Johann D, et al. Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis. Clinical Pharmacology & Therapeutics. 2025;117(1):28-33. doi:10.1002/cpt.3416
BibTeX
@article{Lockwood2025,
author = {Lockwood, Christina M and Merker, Jason D and Bain, Elizabeth and Compton, Caroline and Grossman, Robert L and Johann, Donald and Jones, Frederick and Jones, Gregory and Kreifels, Matthew and LeBlang, Suzanne and Lee, Jerry S H and Lyle, John and Martini, Jean-Francois and Saunders, Lauren and Scher, Howard and Somiari, Stella and Stewart, Mark and Vinson, Jacob and Leiman, Lauren C},
title = {Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
volume = {117},
number = {1},
pages = {28--33},
doi = {10.1002/cpt.3416}
}
EUVIMED